Publications by authors named "Satoshi Kunitada"

Claim this Profile
E
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule.
Dolly A Parasrampuria, Taro Kanamaru, Alyson Connor, Ian Wilding, Koichiro Ogata, Satoshi Kunitada

J Clin Pharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical safety, tolerability, pharmacokinetics and pharmacodynamics of the novel factor Xa inhibitor DY-807f in healthy volunteers.
Koichiro Ogata, Takako Shimizu, Hiroshi Masumoto, Toshihiro Oguma, Nobutoshi Sugiyama, Satoshi Kunitada

Thromb Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation.
Daniel E Salazar, Jeanne Mendell, Helen Kastrissios, Michelle Green, Timothy J Carrothers, Satoshi Kunitada

Thromb Haemost· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.
Meyer Michel Samama, Jeanne Mendell, Céline Guinet, Léna Le Flem, Satoshi Kunitada

Thromb Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of food on the pharmacokinetics of edoxaban, an oral direct factor Xa inhibitor, in healthy volunteers.
Jeanne Mendell, Masaya Tachibana, Minggao Shi, Satoshi Kunitada

J Clin Pharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adults.
Meyer M Samama, Satoshi Kunitada, Andŗe Oursin, Francois Depasse, Stan Heptinstall

Thromb Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation.
Jeffrey I Weitz, Stuart J Connolly, Indravadan Patel, Daniel Salazar, Shashank Rohatagi, Satoshi Kunitada

Thromb Haemost· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers.
Koichiro Ogata, Jeanne Mendell-Harary, Masaya Tachibana, Hiroshi Masumoto, Toshihiro Oguma, Satoshi Kunitada

J Clin Pharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber.
Mohammad Urooj Zafar, David A Vorchheimer, Juan Gaztanaga, Mauricio Velez, Daniel Yadegar, Satoshi Kunitada

Thromb Haemost· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
Richard C Becker, John Alexander, You Fu Li, Edwin Bovill, Frederick A Spencer, Satoshi Kunitada

Thromb Haemost· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor.
Richard C Becker, John H Alexander, Youfu Li, Thomas Robertson, Satoshi Kunitada

J Thromb Thrombolysis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin.
Daichi Shimbo, Julio Osende, Julie Chen, Jonathan Robbins, Yoshimasa Shimoto, Satoshi Kunitada

Thromb Haemost· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.
Christopher K Dyke, Richard C Becker, Neal S Kleiman, Judith S Hochman, Edwin G Bovill, Satoshi Kunitada

Circulation· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor Xa-inhibitor (DX-9065a) modulates the leukocyte-endothelial cell interaction in endotoxemic rat.
Toshiaki Iba, Akio Kidokoro, Masaki Fukunaga, Shoichi Fuse, Masaru Suda, Satoshi Kunitada

Shock· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis